These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transcatheter left atrial appendage closure for stroke prevention among atrial fibrillation patients. Khattab AA; Meier B Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):819-21. PubMed ID: 22908912 [No Abstract] [Full Text] [Related]
6. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device. Möbius-Winkler S; Schuler GC; Sick PB Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653 [TBL] [Abstract][Full Text] [Related]
7. Left Atrial Appendage Closure Under Intracardiac Echocardiographic Guidance: Feasibility and Comparison With Transesophageal Echocardiography. Matsuo Y; Neuzil P; Petru J; Chovanec M; Janotka M; Choudry S; Skoda J; Sediva L; Kurabayashi M; Reddy VY J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27680664 [TBL] [Abstract][Full Text] [Related]
8. First-in-human experience with the Cardia Ultraseal left atrial appendage closure device: The feasibility study. Sabiniewicz R; Hiczkiewicz J; Wańczura P; Stecko W; Curzytek A Cardiol J; 2016; 23(6):652-654. PubMed ID: 27976795 [No Abstract] [Full Text] [Related]
9. Left atrial appendage occlusion devices versus pharmacological agents for stroke prevention in atrial fibrillation: testing the noninferiority margins. Messori A; Fadda V; Maratea D; Trippoli S JACC Cardiovasc Interv; 2014 Aug; 7(8):942-3. PubMed ID: 25147042 [No Abstract] [Full Text] [Related]
10. Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin. Reddy VY; Akehurst RL; Armstrong SO; Amorosi SL; Brereton N; Hertz DS; Holmes DR Europace; 2016 Jul; 18(7):979-86. PubMed ID: 26838691 [TBL] [Abstract][Full Text] [Related]
11. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy. Waksman R; Pendyala LK Am J Cardiol; 2015 Feb; 115(3):378-84. PubMed ID: 25579887 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322 [TBL] [Abstract][Full Text] [Related]
13. Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device. Jaguszewski M; Manes C; Puippe G; Salzberg S; Müller M; Falk V; Lüscher T; Luft A; Alkadhi H; Landmesser U Catheter Cardiovasc Interv; 2015 Feb; 85(2):306-12. PubMed ID: 25205611 [TBL] [Abstract][Full Text] [Related]
15. [Closure of the left atrial appendage when anticoagulation is not working]. Jensen-Urstad M; Sahlgren B; Settergren M Lakartidningen; 2015 Sep; 112():. PubMed ID: 26348049 [No Abstract] [Full Text] [Related]